Eli Lilly (LLY) Operating Income (2009 - 2026)
Eli Lilly (LLY) posted Operating Income of $11.75 billion for Q2 2026, up 67.4% from $7.02 billion a year earlier and up 23.7% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Operating Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Operating Income at Eli Lilly was $38.18 billion, up 73.7% year-over-year; for FY2025, it came in at $29.21 billion, up 80.6% from FY2024.
- Annual Operating Income has increased for five consecutive years, with a five-year compound annual growth rate of 33.7% (FY2020 to FY2025).
- In prior years, Eli Lilly's Operating Income was $16.18 billion in FY2024 (+57.7%), $10.26 billion in FY2023 (+27.6%), $8.04 billion in FY2022 (+9.7%) and $7.33 billion in FY2021 (+7.3%).
- The Q2 2026 figure stands as the highest quarterly Operating Income in data going back to Q1 2009.
- On a year-over-year basis, Operating Income has increased in each of the last 13 quarters, with growth averaging 73.2% over the last eight quarters.
- The strongest year-over-year quarter for Operating Income in the past five years was Q1 2025, with growth of 101.1%; the weakest was Q1 2023, with a decline of 37.8%.
- According to Business Quant data, Operating Income for the three prior quarters was $9.5 billion (Q1 2026), $8.9 billion (Q4 2025) and $8.02 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.75 Bn |
| Mar 31, 2026 | 9.50 Bn |
| Dec 31, 2025 | 8.90 Bn |
| Sep 30, 2025 | 8.02 Bn |
| Jun 30, 2025 | 7.02 Bn |
| Mar 31, 2025 | 5.27 Bn |
| Dec 31, 2024 | 5.34 Bn |
| Sep 30, 2024 | 4.35 Bn |
| Jun 30, 2024 | 3.87 Bn |
| Mar 31, 2024 | 2.62 Bn |
| Dec 31, 2023 | 3.01 Bn |
| Sep 30, 2023 | 3.43 Bn |
| Jun 30, 2023 | 2.22 Bn |
| Mar 31, 2023 | 1.60 Bn |
| Dec 31, 2022 | 2.08 Bn |
| Sep 30, 2022 | 1.74 Bn |
| Jun 30, 2022 | 1.65 Bn |
| Mar 31, 2022 | 2.57 Bn |
| Dec 31, 2021 | 2.35 Bn |
| Sep 30, 2021 | 2.06 Bn |
API Access
Eli Lilly Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();